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Abstract
Whether evolution is erratic due to random historical details, or is repeatedly directed along similar paths by certain
constraints, remains unclear. Epistasis (i.e. non-additive interaction between mutations that affect fitness) is a mechanism
that can contribute to both scenarios. Epistasis can constrain the type and order of selected mutations, but it can also make
adaptive trajectories contingent upon the first random substitution. This effect is particularly strong under sign epistasis,
when the sign of the fitness effects of a mutation depends on its genetic background. In the current study, we examine how
epistatic interactions between mutations determine alternative evolutionary pathways, using in vitro evolution of the
antibiotic resistance enzyme TEM-1 b-lactamase. First, we describe the diversity of adaptive pathways among replicate lines
during evolution for resistance to a novel antibiotic (cefotaxime). Consistent with the prediction of epistatic constraints,
most lines increased resistance by acquiring three mutations in a fixed order. However, a few lines deviated from this
pattern. Next, to test whether negative interactions between alternative initial substitutions drive this divergence, alleles
containing initial substitutions from the deviating lines were evolved under identical conditions. Indeed, these alternative
initial substitutions consistently led to lower adaptive peaks, involving more and other substitutions than those observed in
the common pathway. We found that a combination of decreased enzymatic activity and lower folding cooperativity
underlies negative sign epistasis in the clash between key mutations in the common and deviating lines (Gly238Ser and
Arg164Ser, respectively). Our results demonstrate that epistasis contributes to contingency in protein evolution by
amplifying the selective consequences of random mutations.
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Introduction
Understanding the factors that determine the outcome of
evolution is a long-term goal of evolutionary biology. Epistasis (i.e.
non-additive interactions between mutations that affect fitness) is
one such determinant. Epistasis can affect the type and order of
mutations that can be fixed by natural selection [1,2]. As a result,
it affects the dynamics of evolution, for instance by causing a
mutation to have smaller fitness benefits in the presence than in
the absence of other mutations [3,4]. Under a specific type of
epistasis called sign epistasis, interactions affect not only the size,
but also the sign of the fitness effect of mutations [5]. Sign epistasis
introduces particularly strong evolutionary constraints, and may
create fitness landscapes with multiple adaptive peaks isolated by
valleys of lower fitness [5,6]. In such rugged fitness landscapes,
epistasis can theoretically cause entire mutational pathways to be
contingent on the chance occurrence of initial mutations due to a
combination of two effects. First, once an initial mutation is fixed,
epistasis prevents the selection of alternative initial substitutions.
Next, it concurrently facilitates the selection of mutations that are
beneficial in the background of this particular initial substitution,
but that may be detrimental (or less beneficial) in the background
of alternative initial substitutions.
The predicted evolutionary constraints stemming from epistasis
also depend on the available genetic variation. For example, a
population that is stuck on a suboptimal adaptive peak can escape
from this peak and cross the surrounding fitness valley when
mutants carrying useful combinations of mutations can be
produced. This may be expected to occur in large populations
with a high mutation rate [7], or possibly when there is
recombination [8,9]. For asexual populations, the evolutionary
constraints determined by epistasis are the most pronounced when
the supply of mutations is low and mutations arise and go to
fixation one at a time. In this case, even the smallest fitness valleys
form obstacles for natural selection.
To demonstrate how epistatic constraints affect evolution, one
would ideally need to observe the full sequence of mutational events
and subsequently test the evolutionary consequences of specific
mutational interactions. While sequence divergence data may be
used to study the role of epistasis [10], experimental evolution with
microbes (where replicate lines evolve under identical conditions)
offers a powerful experimental methodology. Such studies have
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shown instances of both divergent and parallel evolution, including
changes in fitness, cell size and genotype [11–16]. A remarkable
case of historical contingency was recently reported in a long-term
evolution experiment with Escherichia coli, when investigators found
that after more than 30,000 generations, multiple ‘potentiating’
mutations allowed one of twelve populations to evolve a key
metabolic innovation [17]. Despite of such findings, identifying the
exact order of mutations, and testing their individual and combined
fitness effects has been challenging even with simple organisms.
Here, we used in vitro evolution of an antibiotic resistance enzyme
to study the effect of epistasis on the process of mutational pathway
diversification. We used TEM-1 b-lactamase, an enzyme that
catalyzes the hydrolysis of ampicillin, and studied its evolution
towards increased activity against the semi-synthetic antibiotic
cefotaxime. Briefly, we introduced random mutations using error-
prone PCR and selected mutant alleles that mediate bacterial
growth in a gradient of cefotaxime concentrations. After each round
of evolution, a fixed mutant allele from each line was isolated from
the highest antibiotic concentration in which bacterial growth was
observed. This system offers the opportunity to study entire adaptive
pathways at the level of phenotype (i.e. antibiotic resistance) and
genotype. Previous studies used the same system to develop
protocols for directed evolution [18], to investigate evolutionary
scenarios [19,20] and to explore the potential of evolution of
resistance to a range of b-lactam antibiotics [21,22]. Collectively,
these studies showed the contribution of both unique and repetitive
substitutions to TEM-1’s adaptation. They also identified a five-fold
mutant (containing a promoter mutation and substitutions A42G,
E104K, M182T and G238S) with an extremely high cefotaxime
resistance [18,23,24]. Measurement of the resistance of constructed
mutants carrying subsets of these mutations revealed substantial sign
epistasis [24–26] and predicted the inaccessibility of most
mutational pathways towards the five-fold mutant [24]. Notably,
several other mutations in addition to the five mentioned above are
capable of increasing cefotaxime resistance, independently or in
combination with other substitutions [25,26]. We were therefore
interested in assessing whether evolution allowing all possible
mutations would always lead to the fivefold mutant or whether
alternative pathways to cefotaxime resistance exist, and to what
extent epistasis plays a role in this.
Results
Diversity of mutational pathways
Twelve replicate lines of the TEM-1 gene were subjected to three
rounds of error-prone PCR followed by selection for increased
cefotaxime resistance. To broadly explore existing adaptive
pathways, we varied the mutation rate (,2 and ,6 nucleotide
substitutions per amplicon per PCR) and introduced a simplified
form of recombination in half of the lines (see Materials and
Methods), although neither of these two treatments appeared to
affect the final level of adaptation, as measured by increases of the
minimal inhibitory concentration (MIC) for cefotaxime (mutation
rate: Mann-Whitney U= 12, two-tailed P= 0.394; recombination:
U= 12, P= 0.394). After each round of evolution, a single clone was
picked from the highest cefotaxime concentration that still
permitted growth. We used this type of bottleneck selection via
the fixation of a single clone [19], because it allowed us to follow the
mutational pathway of the evolving genotypes. In addition,
sequencing indicated that the evolved populations were dominated
by a single clone (see Text S1). Plasmid from the isolated clone was
purified and used as the template for the next round of evolution.
Selected alleles were sequenced and assayed for increased
cefotaxime resistance by measuring the MIC after cloning into
the original vector and transformation into naı¨ve bacterial cells.
Figure 1A shows the changes in MIC for all lines, which levels off
after the second round of evolution, suggesting the approach of one
or more fitness peaks. This pattern is mirrored in the number of
amino acid substitutions recorded per round for the twelve lines (30
substitutions after the first round, 29 after the second round, and 8
after the third, see Table S2). The amino acid substitutions show a
remarkable pattern of parallel response. Seven of the twelve lines
contained the same three substitutions, with G238S always
occurring in the first round, often together with M182T, followed
by E104K in the second round (see Figure 2A, mutation details and
silent mutations for this experiment and subsequent in vitro evolution
experiments can be found in Table S1). Since the promoter region
was not allowed to evolve in our experiments, the main difference
with the previously described adaptive peak (containing A42G,
E104K, M182T and G238S and a promoter mutation) is the
absence of A42G. There is evidence that A42G is a so-called ‘global
suppressor’ substitution [27] and since many such substitutions with
similar functional effects exist [28,29], we suspect that in our
experiments A42G was sometimes replaced by other global
suppressor substitutions (e.g. H153L in line 1 of Figure 2A). We
can not explain the absence of A42G in the lines that contain
E104K, M182T and G238S after two rounds of evolution and
remain unchanged after the third round (lines 5, 9 and 10 in
Figure 2A). However, we would like to point out that the
combination of E104K, M182T, and G238S has occasionally been
reported as the evolutionary end point in other studies [26,30].
Overall, the striking pattern of parallel evolution is consistent with
adaptive constraints from epistasis. Five lines (numbers 3, 4, 7, 11
and 12) deviate from this pattern, because they lack one or more of
the three parallel substitutions and evolve to lower resistance levels
(Mann-Whitney, U= 1, one-tailed P= 0.003).
Epistasis between initial substitutions creates alternative
adaptive pathways
We were interested in testing to what extent epistasis between
different initial substitutions determined the mutational pathways
Author Summary
A long-term goal of evolutionary biology is to understand
the factors that govern the outcome of evolution. Epistasis
(i.e. the situation in which the fitness effect of a mutation
depends on its genetic background) is one such factor.
Epistasis not only affects the dynamics of evolution, it may
also direct its outcome by affecting the type and order of
selected mutations. This effect is particularly strong under
sign epistasis, which occurs when the sign of a mutation’s
fitness effect depends on its genetic background. Here, we
demonstrate how epistasis causes divergence of muta-
tional pathways of an antibiotic resistance enzyme, TEM-1
b-lactamase. First, we use in vitro mutagenesis followed by
selection for cefotaxime resistance to demonstrate that
alternative mutational pathways towards highly resistant
variants exist in addition to the main pathway that was
previously described. Next, to test whether negative
interactions between alternative initial substitutions gov-
ern this diversification, we start identical evolution
experiments with alleles containing initial substitutions
from the deviating lines. These alleles consistently evolve
to lower adaptive peaks and acquire different mutations
than those in the main pathway. Our results demonstrate
that sign epistasis between alternative initial substitutions
may force evolution to follow different mutational
pathways.
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taken. To test this effect of epistasis, we first had to identify the initial
mutations of the common and deviating pathways. Substitution
G238S was found in ten lines after the first round of evolution and is
known to cause the greatest increase in cefotaxime resistance among
all known single TEM-1 mutations [23–25]. We therefore screened
the two lines that lack G238S (lines 3 and 4) for first-round adaptive
substitutions with possible negative epistatic interactions with
G238S, and found a likely candidate in both lines. Substitution
R164S in line 3 has a positive effect on cefotaxime MIC, but shows a
lower MIC when combined with G238S than both substitutions
alone (see [25] and Table 1). Similarly, substitution A237T in line 4
increases activity on cefotaxime [31] and frequently occurs in
clinical isolates, but never in combination with G238S (http://
www.lahey.org/studies/temtable.asp). In our experiments, the MIC
of the double mutant A237T/G238S was equal to that of A237T
alone and only slightly higher than that of TEM-1, but considerably
lower than that of G238S, thus confirming negative epistasis (see
Table S3).
To test the predicted contingent role of these initial mutations,
we ran another set of evolution experiments, this time starting with
TEM-1 alleles carrying either R164S or A237T. We expected that
these mutations would prevent the selection of mutations found in
the common pathway, and instead facilitate the selection of other
mutations. Five replicate lines of each allele were allowed to adapt
to cefotaxime as before, using a mutation rate of,3 mutations per
amplicon (see Text S2 and Table S4). Figure 1B shows the average
change in resistance for all ten new lines, as well as the average for
the twelve lines from the previous experiment. Again, MIC values
levelled off after an initial rise, suggesting that the new lines also
approach one or more adaptive peaks (see also Figure 3B).
However, despite their head start due to the introduced adaptive
mutation, after three rounds of evolution the resistance of these
lines was significantly lower than that reached by the ten G238S-
containing lines in the previous experiment (for both R164S and
A237T lines: U= 3, one-tailed P,0.01), while not significantly
different from each other (U= 12, two-tailed P= 1). The
phenotypic assays, therefore, suggest that R164S and A237T
force evolution to take different adaptive trajectories than the
common trajectory followed by the TEM-1 lines.
The amino acid substitutions found in the new lines confirm this
conclusion (see Figure 3A). First, despite their lower final level of
resistance and lower average mutation rate, the five R164S lines
accumulated more mutations than the ten G238S lines of the
previous experiment (7.2 mutations, without the introduced
R164S, versus 4.7 mutations including G238S, U= 4.5, one-tailed
P= 0.008). Second, mutations in the background of R164S and
A237T occurred at different positions, with relatively more
mutations in the functionally important omega-loop (see Figure
S1) compared to the ten lines carrying substitution G238S (Chi-
square = 8.80, d.f. = 1, P,0.01), suggesting alternative routes
towards the new enzyme functionality. Third, the presence of
substitution R164S or A237T prevented the selection of G238S in
all lines (Fisher’s exact test, P,0.001), and often prevented the
selection of other mutations repeatedly found in the G238S
background, while they facilitated the selection of other mutations.
For example, E104K is more often selected when G238S is present
than when R164S (P= 0.004) or A237T (P= 0.001) are present,
while E240K is more often found in the background of R164S
than with G238S (P= 0.004). Other parallel substitutions, such as
M182T, show a weaker association (i.e. with G238S compared to
R164S, P= 0.036), and appear beneficial in more backgrounds.
Together, the observed changes in phenotype and genotype show
that the introduced substitutions are responsible for the pattern of
parallel and divergent adaptation: they facilitate the selection of
certain mutations, while preventing the selection of others.
Effect of epistasis between non-initial mutations
We have described the effect of epistasis between initial
mutations on mutational trajectories. We were interested to see
how pervasive such epistatic interactions were and whether they
continue to play a role once the first mutational step in a
mutational trajectory has been taken. With this in mind, our
attention was drawn to line 7 of Figure 2A. Like lines 3 and 4, line
7 deviates from the other lines in Figure 2A in that it lacks two of
the three main substitutions E104K, M182T, and G238S: it does
contain G238S, but lacks both E104K and M182T. Because
G238S is present in line 7 after the first round of evolution, we
assumed that either A184V or R191H, the other two substitutions
found after the first round, might be responsible for the atypical
mutational pathway of this line. Because we had observed the
combination of A184V and G238S in pilot experiments and
because A184V is physically very close to M182T, we suspected
Figure 1. Cefotaxime MIC of selected TEM alleles. (A) Adaptation of TEM-1 b-lactamase towards improved hydrolysis of cefotaxime. Lines show
changes in the average Minimal Inhibitory Concentration (MIC) of cefotaxime for the twelve lines shown in Figure 2 (see Table S3 for replicate MIC
values). Aberrant lines 3 and 4 are indicated with solid lines and open and closed triangles, respectively. (B) Increase in cefotaxime MIC for TEM-1
(bold line, the average of Figure 1A) and mutants R164S (open diamonds, dashed line), A237T (diamonds, dashed line), R164S/G238S (open squares)
and A237T/G238S (squares).
doi:10.1371/journal.pgen.1001321.g001
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that this substitution might be a functional equivalent of M182T.
To investigate whether the double mutant A184V/G238S would
prevent other substitutions of the G238S-based pathway from
occurring, we constructed a TEM-1 allele carrying these two
substitutions. The MIC of this double mutant was indeed higher
than that of G238S by itself (see Table S3). Next, we subjected the
A184V/G238S allele to three rounds of error-prone PCR and
selection for increased cefotaxime resistance, again with fivefold
replication, a mutation rate of on average ,3 mutations per
amplicon per error-prone PCR and without recombination. The
amino acid substitutions and MIC-values recorded after each
round of evolution and selection can be found in Figure 4A. Again,
the MIC increases after the 1st and 2nd round, while it levels off in
the 3rd round (Figure 4B). Despite of the head start of the two
introduced mutations, final MIC levels were significantly lower
than those of the seven lines in Figure 2A that contain mutations
M182T and G238S (U= 0, one-tailed P= 0.003). The presence of
A184V in the background of G238S prevented the selection of
M182T (Fisher’s exact test on all 13 lines of Figure 2A and
Figure 4A that contain M182T or A184V in combination with
Figure 2. Amino acid substitutions in evolved TEM-1 alleles. (A) Substitutions are shown as the TEM-1 amino acid according to the IUPAC
single-letter code (left), the position in the protein [39] (middle), and the mutant amino acid (right). Substitutions found after the first round (and
hence in all subsequent rounds) have no shade, those found after the second round have a light shade and those found after the third round have a
dark shade. The three substitutions indicated with an asterisk appeared in the first round, but disappeared again after round 2 (V33I and M155I in line
10) and round 3 (V10I in line 1). Mutation details (including the official nucleotide numbering as in reference [40]) and silent mutations can be found
in Table S1. (B) MIC values of the alleles isolated after the different rounds of evolution, as shown in (A). Values shown are the median value across
three replicates (see Table S3 for replicate measurements). Shading as above.
doi:10.1371/journal.pgen.1001321.g002
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G238S: P= 0.001), but E104K was selected also in this
background (P= 0.07).
More indications for sign epistatic interactions can be found in
Figure 2, Figure 3, and Figure 4. For example, substitutions
E104K and E240K can be found in most lines, but never co-occur
in the same line. Similarly, five out of six lines that contain T265M
lack M182T, and it has been speculated that both substitutions
have a similar (i.e. stabilizing) function [32]. We lack statistical
power to test more interactions due to their low incidence, but our
examples show that sign epistasis in TEM-1 is pervasive and has
adaptive consequences not only for the first, but also for later steps
of the mutational pathway of this enzyme.
Adaptive constraints from pairs of epistatic mutations
Next, we were interested in testing the strength of the adaptive
constraints resulting from sign epistasis directly by allowing alleles
containing combinations of negatively interacting mutations to
evolve. When evolution starts from an allele containing two
negatively interacting mutations, can it alleviate this negative
interaction by the addition of other mutations, or can it only
proceed by the reversion of one of these mutations? Also, does the
strength of sign epistasis affect the strength of the adaptive
constraint, such that stronger sign epistasis limits the adaptive
alternatives? To test this, the negatively interacting R164S/G238S
double mutant, exhibiting a strong negative interaction (see MIC
values for cefotaxime in Table 1), and A237T/G238S, exhibiting
weaker epistasis (see Table S3), were created by site directed
mutagenesis, and subjected to three rounds of directed evolution as
before. The MIC trajectories of the five lines started by both
double mutants show great similarity to those of the twelve TEM-1
lines in the first experiment (see Figure 1B), except that they have
lower MIC-values after the first round of evolution (Figure 2B and
Figure 5B; relative number of MIC doublings after round 1, U= 9,
one-tailed P,0.001).
For the A237T/G238S double mutant, only one line reverted
A237T after the second round, while the other four retained the
introduced mutations at residues 237 and 238 (see Figure 5A, right
half). Interestingly, the line that reverted A237T is the line that
ended up having the highest MIC (see Figure 5B). Three of the
lines that contained both A237T and G238S after three rounds of
evolution did not acquire new substitutions in the third round.
Lack of reversion is unlikely to be an effect of the mutagenesis
protocol, since the a(t) R g(c) transition that can revert both
A237T and G238S, is relatively frequent in the mutational
spectrum of the mutagenic polymerase we applied. It could be that
these lines have gathered mutations in round one and two that
have neutralized the negative interaction between G238S and
A237T and hence made the reversions T237A and S238G either
neutral or detrimental.
The combination of R164S and G238S seems to constrain
evolution more severely, since all five lines eventually reverted
R164S, and four lines did so directly after the first round of
evolution (Figure 5A, left half). One line gathered other mutations
and increased MIC during the first two rounds of evolution, and
reverted R164S after the third round. In this line, in both first two
rounds, at least one mutation was incorporated that is known to be
beneficial in both the R164S and G238S backgrounds (E240K
[33] and M182T [26], respectively). Yet, the reversion S164R in
the third round, combined with other mutations, resulted in a
large increase in resistance, while that of most lines with a first
round reversion levelled off at this point (see Figure 5B). Thus, the
level of selective constraint caused by epistasis varies for different
combinations of mutations, and correlates with the strength of the
negative epistatic interaction for these two cases.
Analysis of the R164S/G238S double mutant
To gain insights into the biochemical basis of the sign epistatic
interaction between R164S and G238S, we purified the double
mutant, and the corresponding single mutants, and examined their
kinetic parameters and stability (see Table 1 and Figures S2 and
S3). On ampicillin, the single mutants and double mutants exhibit
very similar catalytic efficiency (kcat/KM). However, the double
mutant exhibited much lower kcat than both single mutants, in
particular relative to R164S, thus accounting for the lower MIC
on ampicillin at concentrations above the KM. The kinetic
parameters of the double mutant on cefotaxime are essentially
identical to that of the single mutant R164S, but 28-fold lower in
terms of kcat/KM than G238S. These differences correlate with the
Table 1. MIC values and kinetic and stability parameters of TEM-1, single mutants R164S and G238S, and double mutant R164S/
G238S.
TEM-1 R164S G238S R164S/G238S
Ampicillin KM (mM) 7169 3767 2664 11611
Ampicillin kcat (sec
21) 1857697 75625 4261.5 763
Ampicillin kcat/KM (M
21sec21) 2.6*10760.5*107 2.0*10660.8*106 1.4*10660.28*106 0.9*10660.5*106
Ampicillin MIC (mg/ml)a 4096 4096 1024 512
Cefotaxime KM (mM) N.D. 536651 4036126 578626
Cefotaxime kcat (sec
21) N.D. 2.560.1 5063 2.660.1
Cefotaxime kcat/KM (M
21sec21) 1.0*10360.02*103 4.7*10360.4*103 1.30*10560.4*105 4.5*10360.5*103
Cefotaxime MIC (mg/ml)a 0.06 0.5 1.0 0.125
Tm (6C)b 5560.5 5261.5 50 5261
m value 28962.3 30564.5 24862.3 10860.8
The kinetic were acquired in vitro with purified proteins. The Tm and m values (indicating the cooperativity of unfolding) were extracted from heat denaturation. N.D.;
not determined. Errors shown are standard deviations. Because of the high TEM-1 levels under induction, MIC assays for ampicillin were determined without the
addition of IPTG. For additional details see Figures S2 and S3.
aMedian value across three replicates (see Table S3 for replicate measurements).
bThe error ranges for TEM-1 and mutants R164S and R164S/G238S were determined from two independent measurements with two different protein preparations; error
ranges for the remaining variant are estimated to be within the same range.
doi:10.1371/journal.pgen.1001321.t001
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differences in the resistance in vivo (Table 1), but do not account for
the observation that the double mutant exhibits MIC values that
are lower than the R164S mutant, and that are only slightly above
the MIC of TEM-1 itself. Thus, regarding the kinetic parameters,
we observed epistasis between mutations R164S and G238S with
respect to cefotaxime hydrolysis: the R164S substitution eliminates
Figure 3. Amino acid substitutions in evolved TEM-mutants R164S and A237T. (A) See legend of Figure 2A for details. The substitutions
present in the starting alleles and still present at the end of the experiment have been highlighted by a thick-lined box. Note that line 1 of the A237T
alleles acquired substitution R164C after the first round of evolution, and substitution C164Y after the third round. (B) See legend of Figure 2B for
details.
doi:10.1371/journal.pgen.1001321.g003
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the much more beneficial effects of G238S. However, the kinetic
parameters do not account for the sign epistasis observed for the
resistance levels in vivo. The origin of the latter is likely to be lower
levels of functional enzyme, which may result from the lower
kinetic stability of the double mutant. The Tm-values of all three
mutants are similar, and are lower than that of TEM-1. Thus the
thermostability of both single mutants seems comparable to that of
the double mutant. However, the double mutant exhibits a
cooperativity factor (m value) that is ,2.5-fold lower than that of
the two single mutants. In fact, the fit of the double mutant to the
standard two-state unfolding model [34] is poor (see Figure S2),
also indicating that its folding follows a different path than that of
wild-type TEM-1 and of the single mutants. Altogether, the
similarity in kcat and KM values versus the lower MIC, and the
perturbed folding parameters, suggest that sign epistasis relates to
a combination of kinetic parameters that are much lower for the
double mutant than for G238S on its own, and lower levels of
properly folded and functional enzyme.
Discussion
We used laboratory evolution experiments with a model enzyme
to study the topography of its fitness landscape by testing the
involvement of epistasis in creating alternative mutational
pathways. A previous reconstruction of the fitness landscape of
TEM-1 b-lactamase for adaptation to cefotaxime based on MIC
assays of all possible combinations of mutations A42G, E104K,
M182T, G238S, and a promoter mutation suggested that, despite
local ruggedness, it contains a single adaptive peak [24]. However,
by allowing all possible mutations that may contribute to the
evolution of cefotaxime resistance to be selected, we found that the
fitness landscape contains more than a single adaptive peak. Our
ability to monitor and manipulate the sequence of genetic changes
allowed us to demonstrate that epistasis was at the basis of the
landscape’s ruggedness. Epistasis caused one pathway to be used
preferentially, while making the particular choice of pathways
historically contingent upon the first mutational step. This first step
therefore resembles the crucial choice of lanes before a junction of
alternative evolutionary routes. Finally, by studying how the
biochemical and biophysical parameters for a specific pair of
mutations correlate with the level of fitness (here, antibiotic
resistance), we found that sign epistasis resulted from a
combination of negative interactions at the level of enzyme
activity and reduced folding efficiency (kinetic stability).
The epistatic constraints observed in our experiments depend
not only on the topography of the fitness landscape, but also on the
mutation supply rates of the evolving populations (i.e. population
size x mutation rate). The conditions in our experiments were such
that mutation supply rates were in the order of 106 (i.e. library
sizes of ,66105 and mutation rates of ,3 for most experiments)
and multiple mutations were often selected in a single round of
evolution (see Figure 2A). Assuming no mutational bias,
simulations using the PEDEL program [35] indicate that all
possible 2581 single mutants (i.e. 861 nucleotides63 possible
mutations) were present in our libraries, as well as up to 10% of all
possible double mutants. That two of the twelve lines in our first
experiment showed a deviating pattern of substitutions already
after the first round of evolution, therefore, must be seen as a
consequence of epistasis combined with clonal interference
between genotypes carrying different sets of mutations. While
epistatic constraints may be most severe during evolution by
single-mutation selection (the so-called ‘weak-mutation, strong-
selection’ regime), our results show that significant constraints are
experienced also during evolution with much higher mutation
supplies. Because of the high mutation supplies in our experi-
ments, in some lines combinations of mutations that are
individually neutral or deleterious but beneficial in combination
may have been selected. The relative strength of the epistatic
constraints experienced at different scales in genotype space will
depend on the topography of the fitness landscape, and should be
addressed in future work.
How important are our observations on a single enzyme for real
organisms? In our case where mutations affect a single enzyme,
sign epistasis results from the biophysical constraints underlying
functionality of a single protein [36,37]. Although possibly less
severe, similar constraints are likely to exist when mutations affect
different genes and functions [5,6]. Differences observed in the
molecular changes in two bacteriophage populations that evolved
in parallel, indicate that mutational stochasticity and mutational
order may influence the pattern of adaptation [11]. A recent
analysis of epistasis between individually deleterious mutations
affecting different genes of the fungus Aspergillus niger confirms the
significance of sign epistasis for entire organisms [8]. Such epistatic
interactions can make evolution contingent by amplifying the
effects of mutational chance events in finite populations, as
demonstrated here. However, our results also show that even
contingent evolution may have a relatively deterministic structure
once the first step has been determined.
Materials and Methods
Strains and plasmids
Escherichia coli strain DH5aE (Invitrogen) was used as a host for
all plasmids. Plasmid pACSE3 [19] was used as the vector for
cloning and expressing TEM alleles. This ,5.1-kb plasmid
Figure 4. Amino acid substitutions in evolved TEM double-
mutant A184V/G238S. (A) See legend of Figure 2A for details. The
substitutions present in the starting alleles and still present at the end
of the experiment have been highlighted by a thick-lined box. (B) See
legend of Figure 2B for details.
doi:10.1371/journal.pgen.1001321.g004
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contains a tetracycline-resistance marker and replicates at ,10
copies per cell.
Media
LB-medium is 10g/L trypticase peptone, 5 g/L yeast extract and
10 g/L NaCl. LB-tetracycline medium is LB-medium containing
15 mg/L tetracycline and LB-kanamycin medium is LB-medium
containing 50 mg/L kanamycin. Mueller Hinton (Merck) and
Mueller Hinton II (BD) medium were prepared according to the
manufacturers’ instructions. SOC medium is 20 g/L bacto-tryptone
and 5 g/L yeast extract with 10 mM NaCl, 2.5 mM KCl, 10 mM
MgCl2 and 20 mM glucose. Solid media contained 16 g/L agar.
Figure 5. Amino acid substitutions in evolved TEM double-mutants R164S/G238S and A237T/G238S. (A) See legend of Figure 2A for
details. The substitutions present in the starting alleles and still present at the end of the experiment have been highlighted by a thick-lined box.
Note that all R164S substitutions initially present in the five R164S/G238S lines eventually revert, either after the first (lines 2,3,4 and 5) or the third
round of evolution (line 1). Line 1 of the A237T/G238S alleles shows a reversion of A237T after the second round of evolution, while the other four
A237T/G238S lines do not show any reversion. (B) See legend of Figure 2B for details.
doi:10.1371/journal.pgen.1001321.g005
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Recombinant methodology
Plasmids were prepared from overnight LB-tetracycline cultures,
and purified using a GenElute Plasmid Miniprep Kit (Sigma). TEM-
1 (861 bp long) was amplified from pBR322 using the high-fidelity
Pfu polymerase (Stratagene), sense primer P1 (GGGGGGTCAT-
GAGTATTCAACATTTCCGTGTCG, BspHI site underlined, this
enzyme cuts 1 bp upstream of TEM-1’s start codon) and antisense
primer P2 (CCGAGCTCTTGGTCTGACAGTTACCAATGC,
SacI site underlined, this enzyme cuts 17 bp downstream of TEM-
1’s stop-codon), using the following temperature cycle: 309 at 95uC,
309 at 61uC and 909 at 72uC for 30 cycles, followed by 72uC for
10 min. The resulting amplicon was digested with BspHI and SacI
(New England Biolabs). Plasmid pACSE3 was digested with the same
restriction enzymes and dephosphorylated with Calf Intestinal
Phosphatase (New England Biolabs). Digested amplicons and vectors
were purified using Sigma’s GenElute PCR Clean-up Kit, ligated
using T4 DNA Ligase (New England Biolabs), and transformed into
DH5aE by electroporation. Specific mutations were introduced into
TEM-1 using the QuickChange site-directed mutagenesis kit
(Stratagene). Note that in this protocol TEM-1’s promoter region is
not part of the amplicon.
Creation of TEM-1 libraries
Mutant TEM alleles were generated by introducing random
mutations using the Genemorph I and II Mutagenesis Kits
(Stratagene). Since the former kit was unexpectedly taken out of
production and replaced by the latter, we carried out the initial
experiment (Figure 2) using Genemorph I, but were forced to
switch to Genemorph II for all other experiments. Since the error-
prone polymerases in both kits differ only slightly in their
mutational spectrum (see the Genemorph II manual, Stratagene),
this switch has not significantly influenced the outcome of our
experiments. Primers used for error-prone PCR were P3
(TCATCCGGCTCGTATAATGTGGA) and P4 (ACTCTC-
TTCCGGGCGCTATCAT), which flank the multiple cloning
site of pACSE3. In order to make a broad exploration of the
diversity of adaptive pathways, we varied the mutation rate (high
rate in lines 1–6, and low rate in lines 7–12 of Figure 2A) and also
introduced a simplified form of recombination in the initial
experiment (in lines 4–6 and 9–12). The mutation rate was
manipulated by varying the effective number of replication cycles
by the application of different amounts of template DNA.
Conditions were set to introduce on average ,2 (low mutation
rate) or ,6 (high mutation rate) mutations per amplicon (0.06 and
565 ng plasmid template, respectively). The resulting amplicons
were digested with BspHI and SacI, ligated into pACSE3 and
electroporated into DH5aE. After recovery for 90 min in SOC
medium at 37uC, the cells were diluted in 500 mL LB-tetracycline.
An aliquot was taken out directly after mixing and plated onto LB-
tetracycline agar to determine the library size. The remainder of
the culture was incubated at 37uC overnight to amplify the library.
Effective library sizes varied between ,104 and 106 transformants
with an average of ,66105. Aliquots of the amplified libraries
were stored in 10% glycerol at 280uC.
Recombination
In the first experiment, recombination between mutant TEM-1
alleles within a library was allowed in some lines (4–6 and 10–12)
by digestion of the error-prone PCR amplicons with PvuI. TEM-1
has a single PvuI restriction site roughly in the middle of the
sequence, allowing recombination via a single cross-over, as
confirmed by the analysis of restriction markers. The truncated
amplicons were ligated into pACSE3 via a single ligation step as
described above.
Expression and selection
Expression of the TEM-1 allele in pACSE3 is under control of
the pTAC promoter that is tightly regulated by the lac repressor,
encoded by the lacI gene on pACSE3. Expression was induced by
adding 50 mM isopropyl-b-D-thiogalactopyranoside (IPTG),
which was shown to mimic natural expression of TEM-1 [19].
For selection, a series of bottles containing 50 mL Mueller-Hinton
medium (Merck) was inoculated with cefotaxime (Sigma, stock
solution in 0.1 M NaPO4, pH 7.0) concentrations in two-fold
increments, ranging from 0.0625 mg/mL, the MIC of wild-type
TEM-1, to 1024 mg/mL. Each bottle was inoculated with a cell
number approximately equal to 10 times the library size from the
overnight amplified cultures. Cultures were incubated for 48 hours
at 37uC. The culture that grew at the highest concentration of
cefotaxime was plated on LB-tetracycline agar. The presumed
clonal fixation of a single adaptive mutant in these 48 hour
cultures [19] was confirmed by the sequence analysis of 10
randomly picked clones from a single culture (see Text S1).
Therefore, the next day, a single colony was selected and grown
overnight in LB-tetracycline. Plasmid from the overnight culture
was isolated using GeneElute Plasmid Miniprep Kit (Sigma) and
sequenced using BigDye (Perkin Elmer) or DYEnamic (AP-
biotech) Terminator Cycle Sequence kits.
MIC assays
The Minimal Inhibitory Concentration (MIC) was determined
from 150 ml cultures at a titre of 105 cells/mL in Mueller Hinton
II medium containing 50 mm IPTG. A 150 ml solution of twofold
serial dilutions of antibiotic in MH II was added to these cultures.
Cultures were grown for 24 hours at 37uC, growth was
determined by visual inspection, and MIC was defined as the
lowest concentration of antibiotic that completely prevents visible
growth. To exclude phenotypic variation in bacteria, plasmid was
isolated from all selected clones and re-transformed into isogenic
E. coli DH5aE cells prior to each MIC-assay. Ampicillin MICs
were determined without the addition of IPTG, since this turned
out to mask differences between different mutants tested.
Protein purification and thermal denaturation
measurements
Measurements were performed essentially as earlier described
[38]. The equation used to fit the row thermal denaturation was:
y~ aU{q:Tð Þ: 1{ exp mN{U : T{Tmð Þð Þ= {582ð Þð Þððð =
1{ exp mN{U : T{Tmð Þð Þ=RTð Þð ÞÞÞz aN{p:Tð Þð :
1{ exp mN{U : T{Tmð Þð Þ= {582ð Þð Þ= 1{ exp mN{U : T{Tmð Þð Þ=RTð Þð Þð Þ
Where aN is the fluorescence of the native structure at T = 25uC, p
is a slope of fluorescence change of the native state, aU is a
fluorescence at T = 80uC, q is a slope of fluorescence change of the
unfolded state, and mN–U is the slope of transition, RT =2582.
Kinetic measurements
The kinetic parameters kcat and KM were determined by non-
linear regression fit to the Michaelis-Menten equation using the
KaleidaGraph program (Synergy Software). Initial velocities were
recorded with increasing substrate concentrations from 1/3 KM to
3 KM. For ampicillin, hydrolysis of the b-lactam ring was
monitored by loss of absorbance at 232 nm (De= 600 M21 cm21),
using a quartz plate (path of 0.5 cm) in a microtitre plate reader
(bioTeck). The hydrolysis of cefotaxime was monitored by loss of
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absorbance at 264 nm (De= 6360 M21 cm21). Because of the
high initial absorbance, a quartz cell of 0.1 cm pathway was used
for measurements at $250 mM cefotaxime. The readings in lower
concentrations were performed in quartz plate in a plate reader
(path of 0.5 cm).
Statistical analyses
Since MIC values are measured on a discontinuous scale (with
two-fold increases in antibiotic concentration), non-parametric
tests on differences in median MIC estimates were used.
Supporting Information
Figure S1 Three dimensional structure of TEM-1 b-lactamase.
Structure was obtained from the Protein Data Bank (code 1BTL).
The V-loop (residues 161-179) is shown in black. A boronic acid
inhibitor (in grey, obtained from PDB code 1JWZ) has been
modelled in the binding site. The position of residues 104, 164,
237, and 238 has been indicated.
Found at: doi:10.1371/journal.pgen.1001321.s001 (0.92 MB
DOC)
Figure S2 Heat denaturation curves. Purified protein variants of
TEM-1 were subjected to heat denaturation measurements. The
proteins were heated from 25uC to 80uC, and fluorescence
emission at 340 nm was recorded. Panel A shows the raw data,
fitted to the equation described in the Material and Methods
section. Panel B provides the fit to the fraction of folded protein, as
described [40]. Note that the curve describing the double mutant
systematically deviates from the fit, indicating that its unfolding
does not follow a simple, two-state model.
Found at: doi:10.1371/journal.pgen.1001321.s002 (0.39 MB
DOC)
Figure S3 Michaelis-Menten curves for cefotaxime hydrolysis.
The initial velocities (v0) obtained at different cefotaxime
concentrations are plotted versus the decrease initial substrate
concentration ([S]0). The curves were fitted to Michaelis-Menten
equation to obtain the kinetic parameters. The KM of the wild-
type TEM-1 was too high, and a pseudo-first order behaviour was
observed under the applied cefotaxime concentrations. Data were
therefore fitted to a linear curve to obtain kcat/KM.
Found at: doi:10.1371/journal.pgen.1001321.s003 (0.09 MB
DOC)
Table S1 Overview of all synonymous and non-synonymous
mutations found in the selected lines presented in Figure 2,
Figure 3, Figure 4, and Figure 5 of the main text. Mutations
present in the alleles prior to the start of experiments have been
highlighted by a thick-lined box. Substitutions found after the first
round have no shade, those found after the second round have a
light shade and those found after the third round have a dark
shade. Substitutions are shown as the TEM-1 amino acid
according to the IUPAC single-letter code (left), the position in
the protein as in reference [38] (middle), and the mutant amino
acid (right). ‘End’ at the position of the mutant amino acid
indicates a stop-codon, while an asterisk indicates a synonymous
substitution. Nucleotide numbering is given starting from the start
codon (left column) and according to the official numbering as in
reference [39].
Found at: doi:10.1371/journal.pgen.1001321.s004 (0.36 MB
DOC)
Table S2 Number of substitutions recorded per experiment and
per round of evolution.
Found at: doi:10.1371/journal.pgen.1001321.s005 (0.06 MB
DOC)
Table S3 Replicate values of all MIC measurements (in mg/ml).
Found at: doi:10.1371/journal.pgen.1001321.s006 (0.19 MB
DOC)
Table S4 Mutations recorded in 20 unselected clones after
error-prone amplification using Mutazyme II.
Found at: doi:10.1371/journal.pgen.1001321.s007 (0.04 MB
DOC)
Text S1 Check of clonal fixation.
Found at: doi:10.1371/journal.pgen.1001321.s008 (0.03 MB
DOC)
Text S2 Measurement of the mutation rate.
Found at: doi:10.1371/journal.pgen.1001321.s009 (0.03 MB
DOC)
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